Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis (Q43758323)

26 November 2017

Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis (English)

1 reference

26 November 2017

0 references

0 references

1 reference

Paias FO

1

1 reference

26 November 2017

Lanchote VL

series ordinal

2

1 reference

26 November 2017

Takayanagui OM

series ordinal

3

1 reference

26 November 2017

Bonato PS

series ordinal

4

1 reference

26 November 2017

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

22

1 reference

26 November 2017

15

1 reference

26 November 2017

3263-3269

1 reference

describes a project that uses

26 November 2017

capillary electrophoresis

1 reference

based on heuristic

inferred from title

cites work

Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Direct separation of albendazole sulfoxide enantiomers by liquid chromatography on a chiral column deriving from (S)-N-(3,5-dinitrobenzoyl) tyrosine: application to enantiomeric assays on plasma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Application of sulfated cyclodextrins to chiral separations by capillary zone electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Micellar electrokinetic chromatography perspectives in drug analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

A strategy for validation of bioanalytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Selectivity in capillary electrokinetic separations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Electrokinetic separations with micellar solutions and open-tubular capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Therapy for neurocysticercosis: a reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Medical treatment of cysticercosis--effective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Therapy for Neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Small intestinal sulphoxidation of Albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Quantitative determination of albendazole and its main metabolites in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Therapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Chiral capillary electrophoretic analysis of the enantiomeric purity of a pharmaceutical compound using sulfated beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

How to achieve higher repeatability and reproducibility in capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry--2. Statistical analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200109%2922%3A15%3C3263%3A%3AAID-ELPS3263%3E3.0.CO%3B2-4

10.1002/1522-2683(200109)22:15<3263::AID-ELPS3263>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference